Boulder, CO, United States of America

Duncan Walker

USPTO Granted Patents = 10 

 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Location History:

  • Boulder, CO (US) (2017 - 2024)
  • Watertown, MA (US) (2024)

Company Filing History:


Years Active: 2017-2024

Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Title: Duncan Walker: Innovator in Cancer Treatment

Introduction

Duncan Walker, an accomplished inventor based in Boulder, Colorado, has significantly contributed to the field of cancer treatment through his innovative research. With a portfolio of nine patents, he is recognized for his groundbreaking work in targeting specific mutations associated with cancer.

Latest Patents

Among Walker's notable inventions is his work on inhibiting mutant isocitrate dehydrogenase 1 (mIDH-1). Specifically, he has developed a pharmaceutical composition aimed at treating patients diagnosed with cancers harboring an IDH-1 mutation. This composition includes Compound 1, which serves as a selective inhibitor of 2-hydroxyglutarate (2-HG) production from mIDH-1 enzymes. The targeted mutations covered in his patent include R132C, R132H, R132L, R132G, and R132S. This innovation showcases the potential for tailored treatments that could improve outcomes for patients with these specific cancer types.

Career Highlights

Duncan Walker has gained considerable experience within the pharmaceutical industry, working with notable companies such as Forma Therapeutics, Inc. and Array Biopharma Inc. His expertise and dedication to research and development have propelled advancements in medicinal chemistry and targeted therapies.

Collaborations

Throughout his career, Walker has collaborated with several prominent figures in the scientific community. Among his coworkers are Patrick F. Kelly and Alan Collis, both of whom share a commitment to pioneering innovations in healthcare and cancer treatment. These collaborations have undoubtedly enriched Walker's research and broadened the impact of his inventions.

Conclusion

Duncan Walker stands out as a leading innovator in the field of cancer treatment, particularly through his work on mutant isocitrate dehydrogenase 1. His contributions, marked by his extensive patent portfolio and collaborations with industry leaders, underscore the critical role of innovation in advancing medical science and improving patient care. As the landscape of cancer research continues to evolve, Walker's inventions hold promise for future therapeutic strategies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…